Fenwick & West represented Vim Inc., a healthcare technology company that aligns incentives between health plans and care providers to empower value-based care decisions, in its $24M Series B financing led by Optum Ventures and Premera Blue Cross.

Vim will use this investment to fuel rapid expansion across new U.S. markets, and accelerate product development and hiring initiatives. More information about the deal can be obtained from Vim’s announcement.

The Fenwick transaction team included partners Idan Nester and Michael Esquivel, as well as associates Alina Azizian and Lillian Icard.

Login

Don’t have an account yet?

Register